Jay H Shubrook

Author PubWeight™ 13.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Use of case-based reasoning to enhance intensive management of patients on insulin pump therapy. J Diabetes Sci Technol 2008 1.26
2 Evaluating the automated blood glucose pattern detection and case-retrieval modules of the 4 Diabetes Support System. J Diabetes Sci Technol 2010 1.05
3 Characterizing blood glucose variability using new metrics with continuous glucose monitoring data. J Diabetes Sci Technol 2011 0.98
4 Type 2 diabetes mellitus: practical approaches for primary care physicians. J Am Osteopath Assoc 2011 0.89
5 Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy. J Diabetes Complications 2013 0.88
6 A consensus perceived glycemic variability metric. J Diabetes Sci Technol 2013 0.86
7 Racial disparities in African Americans with diabetes: process and outcome mismatch. Am J Manag Care 2012 0.83
8 Diabetes care in extended-care facilities: appropriate intensity of care? Diabetes Care 2007 0.82
9 Analysis of use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in type 1 diabetes mellitus patients treated with multiple daily insulin injections. J Diabetes Sci Technol 2012 0.80
10 Diabetes numeracy and blood glucose control: association with type of diabetes and source of care. Clin Diabetes 2014 0.79
11 Treatment of specific macrovascular beds in patients with diabetes mellitus. Osteopath Med Prim Care 2010 0.79
12 Evaluation of diabetes management in a rural community hospital. Endocr Pract 2008 0.79
13 Evolution of "the guideline advantage": lessons learned from the front lines of outpatient performance measurement. Circ Cardiovasc Qual Outcomes 2014 0.78
14 Use of and attitudes toward complementary and alternative medicine among osteopathic medical students. J Am Osteopath Assoc 2012 0.78
15 How well are we managing diabetes in long-term care? J Fam Pract 2012 0.78
16 Evolution of "the guideline advantage": lessons learned from the front lines of outpatient performance measurement. Diabetes Care 2014 0.76
17 Glycated Hemoglobin Testing to Identify Undiagnosed Diabetes Mellitus in the Inpatient Setting. J Am Osteopath Assoc 2016 0.75
18 Diabetes management within evolving health care delivery models: the osteopathic perspective. J Am Osteopath Assoc 2015 0.75
19 Payer source influence on effectiveness of lifestyle medicine programs. Am J Manag Care 2015 0.75
20 Vitamin D Deficiency, Its Role in Health and Disease, and Current Supplementation Recommendations. J Am Osteopath Assoc 2017 0.75
21 Role of osteopathic structural diagnosis and osteopathic manipulative treatment for diabetes mellitus and its complications. J Am Osteopath Assoc 2013 0.75
22 Effects of Osteopathic Manipulative Treatment on Diabetic Gastroparesis. J Am Osteopath Assoc 2015 0.75
23 Effectiveness of the Complete Health Improvement Program in Reducing Risk Factors for Cardiovascular Disease in an Appalachian Population. J Am Osteopath Assoc 2016 0.75
24 Cardiovascular Disease Risk Factors After an Employer-Based Risk Reduction Program: An Observational Cohort Study. J Am Osteopath Assoc 2017 0.75
25 Be a "great physician" for your patients with type 2 diabetes mellitus. J Am Osteopath Assoc 2012 0.75
26 Inpatient osteopathic structural examinations: is "red tape" getting in the way of personalized patient care? J Am Osteopath Assoc 2008 0.75
27 Evolution of "The Guideline Advantage": Lessons learned from the front lines of outpatient performance measurement. CA Cancer J Clin 2014 0.75
28 Employer-Funded Complete Health Improvement Program: Preliminary Results of Biomarker Changes. J Am Osteopath Assoc 2017 0.75
29 Highlights From the American Diabetes Association's 2017 Standards of Medical Care in Diabetes for Osteopathic Physicians. J Am Osteopath Assoc 2017 0.75
30 Leveraging the principles of osteopathic medicine to improve diabetes outcomes within a new era of health care reform. J Am Osteopath Assoc 2015 0.75
31 GLP-1 agonists: improving the future of patients with type 2 diabetes. J Am Osteopath Assoc 2011 0.75
32 Optimizing treatment for patients with diabetes mellitus: glycemic and nonglycemic effects. J Am Osteopath Assoc 2011 0.75